Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen

REFERENCES

• UN Department of Economic and Social Affairs Population Division. World Contraceptive Use. Accessed 11 June 2010 from: http://www.un.org/esa/population/publications/contraceptive2009/contraceptive2009.htm.
   Google Scholar
• Rosenberg MJ, Meyers A, Roy V. Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: A randomized trial of 20 micrograms and 35 micrograms estrogen preparations. Contraception 999;60:321–9.
   Google Scholar
• Dinger JC, Heinemann LA, Kuhl-Habich D. The safety of a drospirenone-containing oral contraceptive: Final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation. Contraception 2007;75:344–54.
   PubMed Web of Science ®Google Scholar
• Cerel-Suhl SL, Yeager BF. Update on oral contraceptive pills. Am Fam Physician 1999;60:2073–84.
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R. New progestagens for contraceptive use. Hum Reprod Update 2006;12:169–78.
   PubMed Web of Science ®Google Scholar
• Klipping C, Duijkers I, Trummer D, . Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen. Contraception 2008;78:16–25.
   PubMed Web of Science ®Google Scholar
• Nakajima ST, Archer DF, Ellman H. Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe). Contraception 2007;75:16–22.
   PubMed Web of Science ®Google Scholar
• Spona J, Elstein M, Feichtinger W, . Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception 1996;54:71–7.
   PubMed Web of Science ®Google Scholar
• Ansbacher R. The pharmacokinetics and efficacy of different estrogens are not equivalent. Am J Obstet Gynecol 2001;184:255–63.
   PubMed Web of Science ®Google Scholar
• Calaf i Alsina J. After 50 years of ethinylestradiol, another oestrogen in combined oral contraceptives. Eur J Contracept Reprod Health Care 2010;15:1–3.
   PubMed Web of Science ®Google Scholar
• Hoffmann H, Moore C, Zimmermann H, . Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives. Exp Toxicol Pathol 1998;50:458–64.
   PubMed Web of Science ®Google Scholar
• Koetsawang S, Mandlekar AV, Krishna UR, . A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. Contraception 1980;21:445–59.
   PubMed Web of Science ®Google Scholar
• Wenzl R, Bennink HC, van Beek A, . Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiol. Fertil Steril 1993; 60:616–9.
   PubMed Web of Science ®Google Scholar
• Hirvonen E, Allonen H, Anttila M, . Oral contraceptive containing natural estradiol for premenopausal women. Maturitas 1995;21:27–32.
   PubMed Web of Science ®Google Scholar
• Kuhl H. Pharmacology of estrogens and progestogens: Influence of different routes of administration. Climacteric 2005;8(Suppl. 1):3–63.
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R. Pharmacological profile of progestins. Maturitas 2004;47:277–83.
   PubMed Web of Science ®Google Scholar
• Catherino WH, Jordan VC. Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity. J Steroid Biochem Mol Biol 1995;55: 239–46.
   PubMed Web of Science ®Google Scholar
• Lello S. Nomegestrol acetate: Pharmacology, safety profile and therapeutic efficacy. Drugs 2010;70:541–59.
   PubMed Web of Science ®Google Scholar
• Duijkers I KC, Grob P, Korver T. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17ß-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol. Eur J Contracept Reprod Health Care 2010;15:314–25.
   PubMed Web of Science ®Google Scholar
• Committee for medicinal products for human use (CHMP). Guideline on clinical investigation of steroid contraceptives in women. Accessed 18 May 2011 from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003349.pdf.
   Google Scholar
• Benda N, Gerlinger C, van der Meulen EA, . Sample size calculation for clinical studies on the efficacy of a new contraceptive method. Biom J 2004;46:141–50.
   Web of Science ®Google Scholar
• Gerlinger C, Endrikat J, van der Meulen EA, . Recommendation for confidence interval and sample size calculation for the Pearl Index. Eur J Contracept Reprod Health Care 2003;8:87–92.
   PubMed Web of Science ®Google Scholar
• Belsey EM, Farley TM. The analysis of menstrual bleeding patterns: A review. Contraception 1988;38:129–56.
   PubMed Web of Science ®Google Scholar
• Belsey EM, Machin D, d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction. Contraception 1986; 34:253–60.
   PubMed Web of Science ®Google Scholar
• Ahrendt HJ, Nisand I, Bastianelli C, . Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. Contraception 2006;74:451–7.
   PubMed Web of Science ®Google Scholar
• Dinger J. Comparative effectiveness of combined oral contraceptives in adolescents. J Fam Plann Reprod Health Care 2011;37:118.
   PubMed Web of Science ®Google Scholar
• Christin-Maitre S, Serfaty D, Chabbert-Buffet N, . Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17{beta}-estradiol (NOMAC/E2): A double-blind, randomized study. Hum Reprod 2011;26: 1338–47.
   PubMed Web of Science ®Google Scholar
• Dinger J, Minh TD, Buttmann N, . Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen. Obstet Gynecol 2011;117: 33–40.
   PubMed Web of Science ®Google Scholar
• Mueck AO, Sitruk-Ware R. Nomegestrol acetate, a novel progestogen for oral contraception. Steroids 2011;76:531–9.
   PubMed Web of Science ®Google Scholar
• Ezan E, Benech H, Bucourt R, . Enzyme immunoassay for nomegestrol acetate in human plasma. J Steroid Biochem Mol Biol 1993;46:507–14.
   PubMed Web of Science ®Google Scholar
• Ahrendt HJ, Makalova D, Parke S, . Bleeding pattern and cycle control with an estradiol-based oral contraceptive: A seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel. Contraception 2009;80:436–44.
   PubMed Web of Science ®Google Scholar
• Anttila L, Kunz M, Marr J. Bleeding pattern with drospirenone 3 mg + ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg + ethinyl estradiol 20 mcg 21/7 combined oral contraceptive. Contraception 2009;80:445–51.
   PubMed Web of Science ®Google Scholar
• Read CM. New regimens with combined oral contraceptive pills – moving away from traditional 21/7 cycles. Eur J Contracept Reprod Health Care 2010;15(Suppl. 2):S32–41.
   PubMedGoogle Scholar
• Endrikat JS, Milchev NP, Kapamadzija A, . Bleeding pattern, tolerance and patient satisfaction with a drospirenone-containing oral contraceptive evaluated in 3488 women in Europe, the Middle East and Canada. Contraception 2009;79:428–32.
   PubMed Web of Science ®Google Scholar
• Johannes CB, Crawford SL, Woods J, . An electronic menstrual cycle calendar: Comparison of data quality with a paper version. Menopause 2000;7:200–8.
   PubMed Web of Science ®Google Scholar
• Mishell DR, Jr., Guillebaud J, Westhoff C, . Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trials. Contraception 2007;75:11–5.
   PubMed Web of Science ®Google Scholar
• Mishell DR, Jr., Guillebaud J, Westhoff C, . Combined hormonal contraceptive trials: Variable data collection and bleeding assessment methodologies influence study outcomes and physician perception. Contraception 2007;75:4–10.
   PubMed Web of Science ®Google Scholar
• Maloney JM, Dietze P, Jr., Watson D, . Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial. Obstet Gynecol 2008;112:773–81.
   PubMed Web of Science ®Google Scholar
• Koltun W, Lucky AW, Thiboutot D, . Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: A randomized, double-blind, placebo-controlled trial. Contraception 2008; 77:249–56.
   PubMed Web of Science ®Google Scholar
• Coney P, Washenik K, Langley RG, . Weight change and adverse event incidence with a low-dose oral contraceptive: Two randomized, placebo-controlled trials. Contraception 2001;63:297–302.
   PubMed Web of Science ®Google Scholar
• Thiboutot D, Archer DF, Lemay A, . A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment. Fertil Steril 2001;76:461–8.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Odlind V, Meador ML, . A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra). Fertil Steril 2002;77:S19–26.
   PubMed Web of Science ®Google Scholar
• Gallo MF, Lopez LM, Grimes DA, . Combination contraceptives: Effects on weight. Cochrane Database Syst Rev 2008:CD003987.
   Web of Science ®Google Scholar
• Oelkers W, Foidart JM, Dombrovicz N, . Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. J Clin Endocrinol Metab 1995;80:1816–21.
   PubMed Web of Science ®Google Scholar
• Endrikat J, Sandri M, Gerlinger C, . A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 microg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight. Eur J Contracept Reprod Health Care 2007;12:220–8.
   PubMed Web of Science ®Google Scholar
• Ågren UM, Anttila M, Mäenpää-Liukko K, . Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism. Eur J Contracept Reprod Health Care 2011; 16 444–57.
   PubMed Web of Science ®Google Scholar
• Ågren UM, Anttila M, Mäenpää-Liukko K, . Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17b-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function. Eur J Contracept Reprod Health Care 2011; 16 458–67.
   PubMed Web of Science ®Google Scholar